Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes

International Journal of Cardiology

Volumn 111, Issue 1, 2006, Pages 98-103

  Guech Ongey, Mercy ^a   Brenner, Hermann ^a   Twardella, Dorothee ^a   Hahmann, Harry ^b   Rothenbacher, Dietrich ^a  

^a GERMAN CENTRE FOR RESEARCH ON AGEING   (Germany)

^b Klinik Schwabenland   (Germany)

Author keywords

Cytomegalovirus; Diabetes mellitus; Secondary cardiovascular disease event

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IMMUNE DEFICIENCY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; STROKE;

ADULT; AGED; ANTIBODIES, VIRAL; CARDIOVASCULAR DISEASES; CORONARY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33746475149     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.07.028     Document Type: Article

References (23)

1. Bodurtha J., Adler S.P., and Nance W.E. Seroepidemiology of cytomegalovirus and herpes simplex virus in twins and their families. Am J Epidemiol 128 (1988) 268-276
2. Benditt E.P., Barrett T., and McDougal J.K. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A 80 (1993) 6386-6389
3. Minick C.R., Fabricant C.G., Fabricant J., and Litrenta M.M. Athero-arteriosclerosis induced by infection with a herpesvirus. Am J Pathol 96 (1979) 673-706
4. Van Dam-Mieras M.C., Bruggeman C.A., Muller A.D., Debie W.H., and Zwaal R.F. Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res 47 (1987) 69-75
5. Peterslund N.A. Herpesvirus infection: an overview of the clinical manifestations. Scand J Infect Dis Suppl 80 (1991) 15-20
6. Danesh J., Collins R., and Peto R. Chronic infection and coronary heart disease: is there a link?. Lancet 350 (1997) 430-436
7. Sorlie P.D., Nieto F.J., Adam E., Folsom A.R., Shahar E., and Massing M. A prospective study of cytomegalovirus, herpes simplex virus 1 and coronary heart disease: the atherosclerotic risk communities (ARIC) study. Arch Intern Med 160 (2000) 2027-2032
8. Steiner G. Diabetes and atherosclerosis-a lipoprotein prospective. Diabet Med 14 (1997) S38-S44
9. Lin T.M., Chen W.J., Chen H.Y., Wang P.W., and Eng H.L. Increased incidence of cytomegalovirus but no Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation. J Clin Pathol 56 (2003) 429-432
10. Adam E., Melnick J.L., Probstfield J.L., et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2 (1987) 291-293
11. Melnick J.L., Adam E., and DeBakey M.E. Possible role of cytomegalovirus in atherogenesis. JAMA 263 (1990) 2204-2207
12. Melnick J.L., Adam E., and DeBakey M.E. Cytomegalovirus and atherosclerosis. Eur Heart J 14 suppl K (1993) 30-38
13. Yamashiroya H.M., Ghoch L., Yang R., and Robertson Jr. A.L. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 130 (1988) 71-79
14. Ridker P.M., Hennekens C.H., Stampfer M.J., et al. Prospective study of herpes simplex virus, cytomegalovirus, and risk of future myocardial infarction and stroke. Circulation 98 (1998) 2796-2799
15. Roivainen M., Viik-Kajander M., Palosuo T., et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 101 (2000) 252-257
16. Siscovick D.S., Schwartz S.M., Corey L., et al. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and coronary heart disease death in older adults. Circulation 102 (2000) 2335-2340
17. Rothenbacher D., Hoffmeister A., Bode G., Wanner P., Koenig W., and Brenner H. Cytomegalovirus infection and coronary heart disease: results of a German case-control study. J Infect Dis 179 (1999) 690-692
18. Haider A.W., Wilson P.W.F., Larson M.G., et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae and cytomegalovirus with risk of cardiovascular disease. J Am Coll Cardiol 40 (2002) 1408-1413
19. Smieja M., Gnarpe J., Lonn E., Gnarpe H., et al. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 107 (2003) 251-257
20. Zhu J., Nieto F.J., Horne B.D., Anderson J.L., Muhlestein J.B., and Epstein S.E. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103 (2001) 45-51
21. Visseren F.L., Bouter K.P., Pon M.J., Hoekstra J.B., Erkelens D.W., and Diepersloot R.J. Patients with diabetes mellitus and atherosclerosis: a role for cytomegalovirus?. Diabetes Res Clin Pract 36 (1997) 49-55
22. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med (1999) 115-126
23. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143